A Mobile Application for Anticoagulation Management in Patients After Heart Valve Replacement: A Usability Study
Xia Yuan,Shenmin Wan,Wenshuo Wang,Yihong Chen,Ying Lin
DOI: https://doi.org/10.2147/ppa.s471577
2024-09-30
Patient Preference and Adherence
Abstract:Xia Yuan, 1, 2, &ast Shenmin Wan, 1, 2, &ast Wenshuo Wang, 2, 3 Yihong Chen, 1, 2 Ying Lin 1 1 Department of Nursing, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; 2 Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; 3 Shanghai Heart Valve Engineering Technology Research Center, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yihong Chen; Ying Lin, Department of Nursing, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China, Tel +86 21-64041990, Email ; Purpose: Individualized anticoagulation therapy is a major challenge for patients after heart valve replacement. Mobile applications assisted by Artificial intelligence (AI) have great potential to meet the individual needs of patients. The study aimed to develop an AI technology-assisted mobile application (app) for anticoagulation management, understand patients' acceptance of such applications, and determine its feasibility. Methods: After using the mobile application for anticoagulation management for 2 weeks, patients, doctors, and nurses rated its usability using the System Usability Scale (SUS). Additionally, semi-structured interviews were conducted with some patients, doctors, and nurses to gain insights about their thoughts and suggestions regarding the procedure. Results: The study comprised 80 participants, including 38 patients, 18 doctors, and 24 nurses. The average SUS score for patients was 82.37± 5.45; for doctors, it was 84.17± 5.82; and for nurses, it was 81.88± 6.44. This means the patients, physicians, and nurses rated the app highly usable. Semi-structured interviews were conducted on the app's usability with 18 participants (six nurses, three physicians, and nine patients). The interview results revealed that patients found the application of anticoagulation management simple and convenient, with high expectations for a precise dosage recommendation of anticoagulant drugs. Some patients expressed concerns regarding personal information security. Both doctors and nurses believed that elderly patients needed assistance from young family members to use the app and that it could improve patients' anticoagulant self-management ability. Some nurses also mentioned that the use of the app brought great convenience for transitional care. Conclusion: This study confirmed the feasibility of using an AI technology-assisted mobile application for anticoagulation management in patients after heart valve replacement. To further develop this application, challenges lie in continuously improving the accuracy of recommended drug doses, obtaining family support, and ensuring information security. Keywords: anticoagulation management, artificial intelligence (AI) technology, mobile application, heart valve replacement, warfarin Heart valve replacement is the main treatment for severe heart valve diseases. 1 However, patients face risks of negative events such as thrombosis and embolism after valve replacement, making thrombosis prevention essential, and generally requires prolonged anticoagulant therapy. Warfarin is presently the most widely used oral anticoagulant, but it has the disadvantages of a narrow therapeutic window, large inter-individual dose variation, and susceptibility to diet and combined medication. 2 Patients who have undergone bioprosthetic valve replacement need to take warfarin for 3–6 months, while patients who have undergone mechanical valve replacement need to take warfarin for life. 3 Presently, anticoagulation management of Chinese patients is mainly based on outpatient follow-up and self-management, regular blood sampling, medication guidance from doctors, and adjustment of warfarin dose according to the medication habits and experience of different doctors. However, outpatient doctors can only access single-time test results, making it difficult for them to understand the trend of previous continuous laboratory indicators, which are also affected by many factors. Therefore, the accuracy of doctors' judgment is often affected, and the accuracy of warfarin dosing has a significant impact on patients' postoperative rehabilitation and prevention of complications. 4 Achieving precise administration of warfarin is the focus of anticoagulation management in the future. Artificial intelligence (AI) technology has been widely used in medical diagnosis and treatment, especially in personalized precision medicine and new technology research and development. 5 AI can learn and simulate h -Abstract Truncated-
medicine, general & internal